258 related articles for article (PubMed ID: 25365350)
1. Autophagy, inflammation and innate immunity in inflammatory myopathies.
Cappelletti C; Galbardi B; Kapetis D; Vattemi G; Guglielmi V; Tonin P; Salerno F; Morandi L; Tomelleri G; Mantegazza R; Bernasconi P
PLoS One; 2014; 9(11):e111490. PubMed ID: 25365350
[TBL] [Abstract][Full Text] [Related]
2. Human β-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies.
Güttsches AK; Jacobsen F; Theiss C; Rittig A; Rehimi R; Kley RA; Vorgerd M; Steinstraesser L
Innate Immun; 2014 Jan; 20(1):49-60. PubMed ID: 23608825
[TBL] [Abstract][Full Text] [Related]
3. Type I interferon and Toll-like receptor expression characterizes inflammatory myopathies.
Cappelletti C; Baggi F; Zolezzi F; Biancolini D; Beretta O; Severa M; Coccia EM; Confalonieri P; Morandi L; Mora M; Mantegazza R; Bernasconi P
Neurology; 2011 Jun; 76(24):2079-88. PubMed ID: 21670437
[TBL] [Abstract][Full Text] [Related]
4. Dense genotyping of immune-related loci in idiopathic inflammatory myopathies confirms HLA alleles as the strongest genetic risk factor and suggests different genetic background for major clinical subgroups.
Rothwell S; Cooper RG; Lundberg IE; Miller FW; Gregersen PK; Bowes J; Vencovsky J; Danko K; Limaye V; Selva-O'Callaghan A; Hanna MG; Machado PM; Pachman LM; Reed AM; Rider LG; Cobb J; Platt H; Molberg Ø; Benveniste O; Mathiesen P; Radstake T; Doria A; De Bleecker J; De Paepe B; Maurer B; Ollier WE; Padyukov L; O'Hanlon TP; Lee A; Amos CI; Gieger C; Meitinger T; Winkelmann J; Wedderburn LR; Chinoy H; Lamb JA;
Ann Rheum Dis; 2016 Aug; 75(8):1558-66. PubMed ID: 26362759
[TBL] [Abstract][Full Text] [Related]
5. Alpha-chemokine receptors CXCR1-3 and their ligands in idiopathic inflammatory myopathies.
De Paepe B; De Keyzer K; Martin JJ; De Bleecker JL
Acta Neuropathol; 2005 Jun; 109(6):576-82. PubMed ID: 15937690
[TBL] [Abstract][Full Text] [Related]
6. Quantitative whole-body muscle MRI in idiopathic inflammatory myopathies including polymyositis with mitochondrial pathology: indications for a disease spectrum.
Zierer LK; Naegel S; Schneider I; Kendzierski T; Kleeberg K; Koelsch AK; Scholle L; Schaefer C; Naegel A; Zierz S; Otto M; Stoltenburg-Didinger G; Kraya T; Stoevesandt D; Mensch A
J Neurol; 2024 Jun; 271(6):3186-3202. PubMed ID: 38438820
[TBL] [Abstract][Full Text] [Related]
7. Incidence and Prevalence of Idiopathic Inflammatory Myopathies in Korea: a Nationwide Population-based Study.
Cho SK; Kim H; Myung J; Nam E; Jung SY; Jang EJ; Yoo DH; Sung YK
J Korean Med Sci; 2019 Mar; 34(8):e55. PubMed ID: 30833879
[TBL] [Abstract][Full Text] [Related]
8. Polymyositis and dermatomyositis - challenges in diagnosis and management.
Yang SH; Chang C; Lian ZX
J Transl Autoimmun; 2019 Dec; 2():100018. PubMed ID: 32743506
[TBL] [Abstract][Full Text] [Related]
9. Nonimmune mechanisms in idiopathic inflammatory myopathies.
Loredo Martinez M; Zampieri S; Franco C; Ghirardello A; Doria A; Gatto M
Curr Opin Rheumatol; 2020 Nov; 32(6):515-522. PubMed ID: 32890033
[TBL] [Abstract][Full Text] [Related]
10. Survival and cancer risk in an unselected and complete Norwegian idiopathic inflammatory myopathy cohort.
Dobloug GC; Garen T; Brunborg C; Gran JT; Molberg Ø
Semin Arthritis Rheum; 2015 Dec; 45(3):301-8. PubMed ID: 26190563
[TBL] [Abstract][Full Text] [Related]
11. From Diagnosis to Prognosis: Revisiting the Meaning of Muscle ISG15 Overexpression in Juvenile Inflammatory Myopathies.
Hou C; Durrleman C; Periou B; Barnerias C; Bodemer C; Desguerre I; Quartier P; Melki I; Rice GI; Rodero MP; Charuel JL; Relaix F; Bader-Meunier B; Authier F; Gitiaux C
Arthritis Rheumatol; 2021 Jun; 73(6):1044-1052. PubMed ID: 33314705
[TBL] [Abstract][Full Text] [Related]
12. The spectrum of idiopathic inflammatory myopathies in South Africa.
Chinniah KJ; Mody GM
Clin Rheumatol; 2021 Apr; 40(4):1437-1446. PubMed ID: 32212001
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new biomarkers of idiopathic inflammatory myopathy.
Lu X; Peng Q; Wang G
Clin Chim Acta; 2015 Apr; 444():117-25. PubMed ID: 25681646
[TBL] [Abstract][Full Text] [Related]
14. Idiopathic inflammatory myopathies.
van der Kooi AJ; de Visser M
Handb Clin Neurol; 2014; 119():495-512. PubMed ID: 24365315
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.
Haq SA; Tournadre A
Int J Rheum Dis; 2015 Nov; 18(8):818-25. PubMed ID: 26385431
[TBL] [Abstract][Full Text] [Related]
16. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies.
Schwartz T; Diederichsen LP; Lundberg IE; Sjaastad I; Sanner H
RMD Open; 2016; 2(2):e000291. PubMed ID: 27752355
[TBL] [Abstract][Full Text] [Related]
17. Paediatric idiopathic inflammatory muscle disease.
Wedderburn LR; Li CK
Best Pract Res Clin Rheumatol; 2004 Jun; 18(3):345-58. PubMed ID: 15158745
[TBL] [Abstract][Full Text] [Related]
18. Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre.
Loarce-Martos J; Lilleker JB; Parker M; McHugh N; Chinoy H
Rheumatology (Oxford); 2021 Jul; 60(7):3398-3403. PubMed ID: 33367878
[TBL] [Abstract][Full Text] [Related]
19. Using peripheral blood immune signatures to stratify patients with adult and juvenile inflammatory myopathies.
Wilkinson MGL; Radziszewska A; Wincup C; Ioannou Y; Isenberg DA; Manson JJ; Jury EC
Rheumatology (Oxford); 2020 Jan; 59(1):194-204. PubMed ID: 31292651
[TBL] [Abstract][Full Text] [Related]
20. Chemokines in idiopathic inflammatory myopathies.
De Paepe B; Creus KK; De Bleecker JL
Front Biosci; 2008 Jan; 13():2548-77. PubMed ID: 17981734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
